The Global Molecular Biology Enzymes, Kits & Reagents Market size was valued at USD 13.1 Bn in 2020 is expected to reach USD 33.9 Bn by 2027, with a growing CAGR of 14.2 % during the forecast period.
The Enzymes and kits & reagents are the basic tools for molecular biology. The enzymes in molecular biology include Proteinase K, RNase A, T4 DNA Ligase, DNase I, RNAse Inhibitor or Bovine Factor XA, Calf Intestinal Alkaline Phosphatase (CIAP), and Exonuclease I (E. coli). Increasing demand for molecular Biology Enzymes and Kits & Reagents and the adoption of nucleic acid analysis contribute to propelling the molecular biology enzymes and kits & reagents market during the forecast period.
The rapid development of reagents and kits by the key players has resulted in a good sale of molecular biology enzymes and kits & reagents products. The product acquisition and launches by numerous key players is considerably the propelling factor in the molecular biology enzymes and kits & reagents market. For instance, in March 2021, Creative Enzymes announced the launch of its molecular tools. The company is focused on the development of enzyme tools that qualify the research and development field.
The awareness for molecular analysis for various diagnosis is the major driving factors influencing the growth of the molecular Biology enzymes and kits & reagents market.
The various government initiatives for disease detection drive the biology enzymes and kits & reagents market across the globe. For instance, the awareness for cancer and other chronic diseases increases the diagnosis rate, driving the molecular biology enzymes and kits & reagents market. The increasing research on cell culture and its investments drive the molecular biology enzymes and kits & reagents market.
Molecular Biology Enzymes and Kits & Reagents market Segmentation:
By Product
By Application
By End user
By Region
Based on product, the kits & reagents segment held the largest market share in 2020 and is accounted to hold the dominance during the forecast period.
Based on products, the kits & reagents segment has gained a tremendous molecular biology enzymes and kits & reagents market share in 2020 and is expected to expand in the share during the forecast period. The launches and acquisitions held by the key players also accelerate the molecular biology enzymes and kits & reagents market. For instance, in March 2019, Asuragen, Inc. launched AmplideX PCR/CE SMN1/2 Kit for the detection of SMN2 and SMN1 in around 4 hours. The kits were based on polymerase chain reaction testing for molecular diagnostic purposes.
Based on application, the polymerase chain reaction segment held the largest market share in 2020 due to increasing usage of PCR for detection
Based on application, the polymerase chain reaction segment accounted for the largest market share in 2020. This is due to the low cost and maintenance of PCR equipment, the increasing use of PCR for molecular diagnostic analysis in laboratories, hospitals, and clinics, and the extensive use of PCR equipment by most of the end-users.
Based on end-user, the academic & research institutes segment had the largest market share in 2020 due to the rise in funding for research and development
Based on technique, the academic & research institutes segment has accounted for the largest market share in 2020. This is due to the rise in funding from governments and non-profit organizations for research and development in life science. The continuous research and development activities and the clinical trials in the leading key players drive the demand for the molecular Biology Enzymes and Kits & Reagents market.
Based on region, North America accounted for the largest market shares in 2020 and is expected to maintain the dominance over during the forecast period
Based on region, North America dominated the molecular biology enzymes and kits & reagents market in 2020. The region has a high demand for molecular biology enzymes and kits & reagents due to the increasing molecular analysis for chronic diseases and funding for research and development in the region. The region is attributed to the largest share due to its increasing healthcare expenditure and well-established healthcare infrastructure. Many key players are investing in acquisitions, merges, and launches in the molecular biology enzymes and kits & reagents market.
Companies concentrated on innovative products to increase the accuracy in the analysis of molecular biology diagnosis. For instance, in May 2019, Crystal Taq was launched by Pharmozyme, Inc., to avoid bacterial and animal DNA contamination and reduces PCR background contamination. The test is accurate and cost-effective.
The molecular biology enzymes and kits & reagents market in the Asia Pacific is expected to grow at the highest rate during the forecast period due to the presence of bio-clusters in India and China, the increasing government interest in the biomedical & biotechnology industries, and the growing research and development in clinical research activities.
Company Profiles and Competitive Intelligence
The key players operating in the molecular biology enzymes and kits & reagents market are:
The report also provides in-depth analysis of molecular biology enzymes and kits & reagents market dynamics such as drivers, restraints, opportunities, and challenges
Drivers
Restraints
Opportunities
Challenges
COVID-19 Impact on the molecular biology enzymes and kits & reagents market analysis
The COVID-19 outbreak experienced a positive impact on the molecular biology enzymes and kits & reagents industry as it has increased in terms of growth and revenue generation. This was due to the high demand for molecular analysis and diagnosis for the individuals suffering or infected from the virus. PCR tests are regarded as one of the best tests to analyze COVID-19 owing to their reliability and accuracy in detecting genetic materials in the virus.
The COVID-19 cases were increasing day by day and the lockdown was imposed across the world. According to World Health Organization and European Centre for Disease Prevention and Control, there are about 200 million confirmed cases of COVID-19 which have been reported across the globe.
The report also provides an in-depth analysis of key trends in the Molecular Biology Enzymes and Kits & Reagents market
The report also provides an in-depth analysis of recent news developments and investments
The unique insights provided by this report also includes the following:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
Log in / Register
